The Drug Enforcement Administration and Department of Health and Human Services have finalized the Expansion of Buprenorphine Treatment via Telemedicine Encounter Rule, nearly two years after it was proposed.
Sean Sullivan, Sofia Molodanof, and Anthony Fanucci examine the final rule on prescribing buprenorphine via telemedicine that was published on January 15, 2025. They discuss the key components of the rule, the implication it leaves for stakeholders, and whether the Trump Administration could revise or kill the rule.
Subscribe to Our Health Care Updates >
View More Healthy Bytes > | Return to Digital Transformation of Health Care >